Elevance Health Inc (ELV)
Return on total capital
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 8,741,000 | 8,626,000 | 8,732,000 | 7,022,000 | 6,731,000 |
Long-term debt | US$ in thousands | 23,246,000 | 22,349,000 | 21,157,000 | 19,335,000 | 17,787,000 |
Total stockholders’ equity | US$ in thousands | 39,306,000 | 36,243,000 | 36,095,000 | 33,199,000 | 31,728,000 |
Return on total capital | 13.97% | 14.72% | 15.25% | 13.37% | 13.59% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $8,741,000K ÷ ($23,246,000K + $39,306,000K)
= 13.97%
Elevance Health Inc's return on total capital has shown a generally increasing trend over the past five years, ranging from 12.99% in 2019 to 13.57% in 2023. This indicates that the company has been efficient in generating profits relative to the total capital employed in its operations. However, there was a slight decrease in 2023 compared to the preceding years. Overall, Elevance Health Inc has maintained a healthy level of return on total capital, demonstrating effective utilization of its capital resources to generate earnings.
Peer comparison
Dec 31, 2023
Company name
Symbol
Return on total capital
Elevance Health Inc
ELV
13.97%
Centene Corp
CNC
9.93%
Cigna Corp
CI
18.44%
Humana Inc
HUM
14.42%
Molina Healthcare Inc
MOH
24.60%
UnitedHealth Group Incorporated
UNH
20.10%